Biogen

Biogen

Quarterly Financials

Values in thousands2026-06-302026-03-312025-12-312025-09-30
Revenue
$2,736,000
$2,477,800
$2,279,300
$2,454,800
Gross Profit
1,557,399
1,816,800
1,783,000
1,578,200
EBITDA
78,200
553,600
212,200
826,900
EBIT
214,700
417,100
-143,500
624,700
Net Income
97,500
319,500
-48,411
466,500
Net Change In Cash
2,736,000
2,477,800
2,279,300
2,454,800
Free Cash Flow
489,800
696,700
555,900
1,226,300
Cash
1,285,000
3,382,700
3,008,500
3,862,800
Basic Shares
148,700
148,400
146,700
147,100

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$9,810,600
$9,675,900
$9,835,600
$10,173,400
Gross Profit
6,913,600
7,365,500
7,302,200
7,895,100
EBITDA
3,100,600
2,995,700
2,377,000
3,536,900
EBIT
2,165,200
2,322,500
1,882,200
3,018,500
Net Income
1,293,389
1,632,200
1,161,100
3,046,900
Net Change In Cash
9,810,600
9,675,900
9,835,600
10,173,400
Cost of Revenue
1,213,600
Free Cash Flow
2,050,800
2,515,700
1,235,800
1,144,000
Cash
3,008,500
2,375,000
1,049,900
3,419,300
Basic Shares
146,700
145,900
145,600
146,000

Earnings Calls

QuarterEPS
2026-06-30
$3.60
2026-03-31
$3.57
2025-12-31
$1.99
2025-09-30
$4.81